Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies. J of Skin [Internet]. 2020 Oct. 27 [cited 2025 Oct. 31];4(6):s95. Available from: https://skin.dermsquared.com/skin/article/view/1065